Randomized phase II study of gemcitabine plus radiotherapy versus gemcitabine, 5-fluorouracil, and cisplatin followed by radiotherapy and 5-fluorouracil for patients with locally advanced, potentially resectable pancreatic adenocarcinoma

Jerome Landry*, Paul J. Catalano, Charles Staley, Wayne Harris, John Hoffman, Mark Talamonti, Natalie Xu, Harry Cooper, Al B. Bensoniii

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

111 Scopus citations

Fingerprint Dive into the research topics of 'Randomized phase II study of gemcitabine plus radiotherapy versus gemcitabine, 5-fluorouracil, and cisplatin followed by radiotherapy and 5-fluorouracil for patients with locally advanced, potentially resectable pancreatic adenocarcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences